On 2026-08-20, PharmaCorp Rx Inc. (V.PCR) announced earnings per share of 0.00 for the fiscal quarter ending 2026-06-30, meeting the average analyst estimate of 0.00.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-20 | 2026-06-30 | 0.00 | 0.00 |